Rd Funding Sample Clauses

Rd Funding. Biogen Idec shall make a [****] non-creditable, non-refundable R&D funding payment to PDL within [****] after approval by the JSC of a [****] to the JSC following the Effective Date.

Rd Funding. Funding of the research under the Projects shall be in accordance with Section 3.5 as further outlined in the Work Plan and applicable Project Plans.

Rd Funding. During the period commencing on the Effective Date and continuing on a Licensed Product by Licensed Product basis until the earlier of (a) the exercise by ImmunoGen of a Co-Development Option with respect to such Licensed Product and (b) the expiration of the Research Program term, Biotest shall pay ImmunoGen the aggregate FTE Cost for all FTEs used by ImmunoGen in the conduct of ImmunoGen Activities on a quarterly basis, based on the FTE Rate and the Research Plan and/or Development Plan. Within [***] ([***]) days following the last day of each Calendar Quarter during the conduct of the Research Program, ImmunoGen shall issue an invoice reflecting the FTE Costs for such Calendar Quarter, as reflected in the then-current Research Plan and Biotest shall pay each such invoice within [***] ([***]) days from receipt. The amount invoiced for ImmunoGen Activities performed by an FTE shall be calculated based on [***] [***] [***] using an [***] [***] [***] and [***] of [***] in a [***] [***] [***] the [***] of [***] [***] [***] such ImmunoGen Activities, based on a total of [***] hours in an FTE year. Such invoice shall have attached to it a copy of the [***] [***] [***] of [***] [***] [***] to the [***] [***] on such particular invoice. If, at any time during the Term of this Agreement, ImmunoGen determines that the actual number of FTEs for a particular Calendar Quarter agreed to by the Parties is expected to exceed by [***] percent ([***]%) the [***] [***] set forth in such Research Plan for such Calendar Quarter, ImmunoGen shall give Biotest prompt written notice of same and the Parties shall discuss in good faith whether to [***] the [***] of such [***] [***] or to [***] the [***] to be [***], such that such [***] [***] are [***] [***]. The JDC shall be the forum for discussions about an extension of ImmunoGen Activities not covered by the budget as laid down in the Research Plan.

Rd Funding. In addition to the milestone payments due under ----------- Section 7.1 hereof, Schering agrees to reimburse Zonagen for the reasonable actual out-of-pocket expenses (which have not otherwise been reimbursed by Schering-Plough Ltd. pursuant to the Ex-U.S. License Agreement) Zonagen has incurred or incurs in conducting the ongoing open-label study of the Licensed Product, which open-label study is identified by Zonagen as Study ZON303. Notwithstanding the foregoing, Schering's total obligation to reimburse Zonagen in accordance with this Section 7.2 shall not exceed ***. Schering's reimbursement of such expenses pursuant to this Section 7.2 will be made in installments, pursuant to invoices submitted by Zonagen to Schering, which invoices shall include documentation *** This portion has been omitted based on a request for confidential treatment pursuant to Rule 24b-2 of the Exchange Act. The omitted portion has been separately filed with the Commission. (including, without limitation, invoices Zonagen has received from third parties) that supports the amount of expenses for which Schering is being invoiced. Zonagen shall submit to Schering an invoice for the first such installment upon the filing with the FDA of an NDA supporting U.S. Regulatory Approval of the Licensed Product, which installment, subject to the limitations set forth in this Section 7.2, shall be in the amount of such actual out-of-pocket expenses incurred by Zonagen prior to such time. Thereafter, Zonagen shall submit to Schering invoices and supporting documentation within thirty (30) days after the end of each Calendar Quarter, which invoices, subject to the limitations set forth in this Section 7.2, shall be for the reasonable actual out-of-pocket expenses incurred by Zonagen during such Calendar Quarter. Each such invoice shall be payable within sixty (60) days after Schering's receipt of the invoice.

Rd Funding. No funding, facilities or resources of any government, military, university, college, other educational institution or research center (“R&D Sponsor”) was or is used in the development of the Company Products, Owned Company Intellectual Property or Technology owned or purported to be owned by the Company Group, and no employee or contractor who developed or created any Owned Company Intellectual Property was employed by or has performed services for any R&D Sponsor during the period of time during which such Person was also performing services for the Company Group, in each case, in a manner that would grant such R&D Sponsor any rights to any Company Intellectual Property. No R&D Sponsor has made in writing any claim of right to, ownership of or other Lien on any Owned Company Intellectual Property. Section 3.18(k) of the Disclosure Schedule sets forth a list of all agreements between a member of the Company Group and a R&D Sponsor relating to the development of the Company Products, Owned Company Intellectual Property or Technology that was in effect at any time since the date that is five (5) years prior to the date of this Agreement.

Rd Funding